Skip to content

Estrogen did not show a clear added chair-stand benefit alongside resistance exercise

A blinded trial in older women with knee osteoarthritis found no statistically significant overall advantage on its primary physical performance outcome.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Adding estrogen to resistance exercise did not produce a statistically significant overall improvement in chair-stand performance compared with placebo plus exercise. This does not prove that an added effect is absent. Signals involving early-stage osteoarthritis and mental health were exploratory and cannot establish which women would benefit from adding estrogen.

Keep in mind

The subgroup findings were post hoc. The abstract does not provide detailed later follow-up results, and the absence of serious adverse events in this trial cannot establish safety more broadly.

THE NUMBERS, WITH CONTEXT

What researchers found

0.81 repetitions; 95% CI: -0.31 to 1.92; P = .16

Between-group difference in chair-stand improvement

Regression coefficient for estrogen versus placebo, both with exercise, at 3 months on the 30-second chair stand test.

Age Ageing, 2025 · Original source ↓

The main result takes priority

Chair-stand scores improved in both groups, but the primary analysis did not demonstrate an additional estrogen effect. Because both groups exercised, this comparison addresses adding estrogen and does not isolate the effect of exercise itself.

Exploratory signals need confirmation

Additional analyses suggested possible benefits among participants with early-stage knee osteoarthritis, and mental health scores improved in the estrogen group. Those observations raise research questions but do not overturn the uncertain overall result for physical performance.

CHECK THE ORIGINAL

The original publication

Oestrogen replacement combined with resistance exercise in older women with knee osteoarthritis: a randomised, double-blind, placebo-controlled clinical trial.

Mitoma T, Ooba H, Takahashi K et al.
Age Ageing · 2025

PubMed ID
40794913
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.